Morgan Stanley Neuro Pace Inc Call Options Transaction History
Morgan Stanley
- $1.36 Trillion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|---|---|---|---|---|
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
Others Institutions Holding NPCE
# of Institutions
93Shares Held
24.6MCall Options Held
1.8KPut Options Held
300-
Orbimed Advisors LLC San Diego, CA3.41MShares$34.7 Million1.3% of portfolio
-
Polar Capital Holdings PLC London, X02.97MShares$30.3 Million0.24% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.61MShares$26.6 Million2.65% of portfolio
-
First Light Asset Management, LLC Edina, MN1.58MShares$16.2 Million2.5% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.2MShares$12.2 Million0.0% of portfolio
About NeuroPace Inc
- Ticker NPCE
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,846,900
- Market Cap $253M
- Description
- NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and ena...